Literature DB >> 32645946

Cationic Nanostructures for Vaccines Design.

Ana Maria Carmona-Ribeiro1, Yunys Pérez-Betancourt1.   

Abstract

Subunit vaccines rely on adjuvants carrying one or a few molecular antigens from the pathogen in order to guarantee an improved immune response. However, to be effective, the vaccine formulation usually consists of several components: an antigen carrier, the antigen, a stimulator of cellular immunity such as a Toll-like Receptors (TLRs) ligand, and a stimulator of humoral response such as an inflammasome activator. Most antigens are negatively charged and combine well with oppositely charged adjuvants. This explains the paramount importance of studying a variety of cationic supramolecular assemblies aiming at the optimal activity in vivo associated with adjuvant simplicity, positive charge, nanometric size, and colloidal stability. In this review, we discuss the use of several antigen/adjuvant cationic combinations. The discussion involves antigen assembled to 1) cationic lipids, 2) cationic polymers, 3) cationic lipid/polymer nanostructures, and 4) cationic polymer/biocompatible polymer nanostructures. Some of these cationic assemblies revealed good yet poorly explored perspectives as general adjuvants for vaccine design.

Entities:  

Keywords:  biomimetic lipid/polymer nanoparticles; cationic adjuvants; cationic lipids; cationic nanoparticles; cationic polymer /biocompatible polymer assemblies; dioctadecyldimethylammonium bromide; poly (acrylates); poly cations

Year:  2020        PMID: 32645946     DOI: 10.3390/biomimetics5030032

Source DB:  PubMed          Journal:  Biomimetics (Basel)        ISSN: 2313-7673


  6 in total

1.  Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation.

Authors:  Dipika Nandi; Manisha Shivrayan; Jingjing Gao; Jithu Krishna; Ritam Das; Bin Liu; S Thayumanavan; Ashish Kulkarni
Journal:  ACS Appl Mater Interfaces       Date:  2021-09-20       Impact factor: 10.383

2.  Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.

Authors:  Yelixza I Avila; Morgan Chandler; Edward Cedrone; Hannah S Newton; Melina Richardson; Jie Xu; Jeffrey D Clogston; Neill J Liptrott; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Molecules       Date:  2021-01-27       Impact factor: 4.411

3.  Biocompatible Lipid Polymer Cationic Nanoparticles for Antigen Presentation.

Authors:  Yunys Pérez-Betancourt; Bianca de Carvalho Lins Fernandes Távora; Eliana L Faquim-Mauro; Ana Maria Carmona-Ribeiro
Journal:  Polymers (Basel)       Date:  2021-01-07       Impact factor: 4.329

4.  Biomimetic Nanotechnology Vol. 2.

Authors:  Ille C Gebeshuber
Journal:  Biomimetics (Basel)       Date:  2022-01-14

Review 5.  Supramolecular Nanostructures for Vaccines.

Authors:  Ana Maria Carmona-Ribeiro
Journal:  Biomimetics (Basel)       Date:  2021-12-29

Review 6.  Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?

Authors:  Shiyi Zuo; Jiaxuan Song; Jingxuan Zhang; Zhonggui He; Bingjun Sun; Jin Sun
Journal:  Theranostics       Date:  2021-06-01       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.